Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: A Gynecologic Oncology Group study

Gynecologic Oncology

Volumn 36, Issue 2, 1990, Pages 166-171

  Morrow, C Paul ^a   Bundy, Brian N ^b   Homesley, Howard D ^c   Creasman, William T ^d   Hornback, Ned B ^e   Kurman, Robert ^f   Thigpen, J Tate ^g  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN;

ADJUVANT CHEMOTHERAPY; ARTICLE; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STAGING;

COMBINED MODALITY THERAPY; DOXORUBICIN; FEMALE; HUMAN; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, UNKNOWN PRIMARY; RANDOM ALLOCATION; RISK FACTORS; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL ANALYSIS; UTERINE NEOPLASMS;

EID: 0025021388     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/0090-8258(90)90166-I     Document Type: Article

References (4)

1. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma
2. Phase II trial of adriamycin in the treatment of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study
3. Surgical staging in endometrial cancer: Clinicopathologic findings in a prospective study
4. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study